Ocugen (OCGN) Capital Expenditures Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 16.27% |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -84.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.50% |
| Dec 31, 2025 | 28.24% |
| Sep 30, 2025 | -26.42% |
| Jun 30, 2025 | 33.11% |
| Mar 31, 2025 | -70.30% |
| Dec 31, 2024 | -59.24% |
| Sep 30, 2024 | 31.49% |
| Jun 30, 2024 | 111.66% |
| Mar 31, 2024 | 12.44% |
| Dec 31, 2023 | 121.35% |
| Sep 30, 2023 | 291.68% |
| Dec 31, 2022 | -803.01% |
| Jun 30, 2022 | -141.55% |
| Mar 31, 2022 | 286.52% |
| Sep 30, 2021 | 31.75% |
| Jun 30, 2021 | 92.71% |
| Mar 31, 2021 | -33.93% |
| Dec 31, 2020 | 20.35% |
| Sep 30, 2020 | -0.59% |
| Dec 31, 2019 | -39.06% |
| Jun 30, 2019 | -26.62% |
| Mar 31, 2019 | -30.85% |
| Sep 30, 2018 | -52.68% |
| Jun 30, 2018 | -28.58% |
| Mar 31, 2018 | -0.37% |
| Dec 31, 2017 | -56.45% |
| Sep 30, 2017 | -65.47% |
| Jun 30, 2017 | -19.56% |
| Mar 31, 2017 | -32.44% |